$TLRY

Merton Carl A purchased $46K of TLRY

Merton Carl A (Chief Financial Officer) purchased 10,000 shares of Tilray Brands, Inc. (TLRY) at $4.62 on 2026-08-04.

Original reporting
SEC EDGAR · Merton Carl A
Published Aug 4, 2026, 5:36 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 6:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TLRY
Neutral
medium confidence
Mentioned
$TLRY
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TLRYNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market purchase details (10,000 shares at $4.62) filed on 2026-08-04; no other company-specific catalyst is included.

02

Market read

Traders may note the insider buy as a mild sentiment input, but the filing alone is unlikely to drive a durable repricing without additional fundamental news.

03

What to watch

The article provides no context on prior insider activity, option exercises, or whether the CFO has ongoing compensation-driven buying patterns.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-04 (same day as transaction)

Background

This is an SEC Form 4 insider transaction disclosure for Tilray Brands, Inc.

Company-level read

Ticker impact

$TLRYNeutralMedium confidence
Context

Tilray CFO Merton Carl A filed a Form 4 open-market purchase of 10,000 shares at $4.62 on 2026-08-04.

Expected impact

Likely limited near-term price impact; any effect is sentiment-driven and should fade unless followed by additional disclosures.

Evidence & confidence

Form 4 insider buys can be read as confidence, but the transaction size ($46.2k) is modest versus typical market-moving thresholds, and there is no accompanying guidance, deal, or regulatory event in the text.

Market effects

No sector-level implications are disclosed; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine liquidity or diversification actions, and the absence of a 10b5-1 plan does not guarantee a bullish fundamental thesis.

Key entities

  • Tilray Brands, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Merton Carl A

    Tilray CFO who purchased 10,000 shares open-market at $4.62.

Related articles

$TLRYMed

Tilray Brands (TLRY) Is Up 5.7% After Narrower Loss, ESOP Shelf Filing and M&A Signal

Tilray Brands reported Q4 sales of US$281.71 million and full-year sales of US$915.45 million for the year ended May 31, 2026, with a substantially smaller net loss than the prior year. The company also filed a US$47.69 million shelf registration for 11,355,231 common shares tied to its ESOP. Management said at-the-market equity proceeds may fund acquisitions, including deals like BrewDog.

$TLRYMed

Tilray Brands Q4 Earnings Call Highlights

Tilray Brands (NASDAQ: TLRY) reported fiscal 2026 results on its Q4 earnings call. Net loss narrowed to $105.2M ($1.09/share) from about $2.2B in fiscal 2025. Adjusted net income rose 87% to $12.2M. Cannabis and distribution revenue grew, BrewDog added beverage revenue, and Tilray guided adjusted EBITDA of $68M to $75M for fiscal 2027.

$TLRYMed

Tilray Brands reports record US$915.5M revenue in Fiscal 2026

Tilray Brands reported record fiscal 2026 revenue of US$915.5M, up 11% from US$821.3M, driven by cannabis, beverage, distribution and wellness. Beverage net revenue rose 6% to US$254.0M, with Q4 beverage revenue up 61% to US$105M. Adjusted EBITDA increased to US$61.1M. Tilray completed a £33M BrewDog acquisition in March. It forecasts fiscal 2027 adjusted EBITDA of US$68M to US$75M.

$TLRYMedAI 8/10

Tilray Brands Q4 revenue beats estimates by 10.7%, shares rise 2.23%

Tilray Brands reported Q4 net revenue of $281.7 million for the period ended May 31, up 10.7% versus the $254.53 million consensus estimate, and shares rose 2.23% to $4.12 after hours. Adjusted EPS was $0.05, missing the $0.21 consensus. For FY26, net revenue rose 11% to $915.5 million; adjusted EBITDA increased to $61.1 million.